![](/img/cover-not-exists.png)
Evaluation of the QTc interval during lenvatinib treatment in radioiodine-refractory differentiated thyroid cancer: reports from the real-life clinical practice
Marina, Michela, Serra, Maria Francesca, Rio, Paolo Del, Ceresini, GrazianoLanguage:
english
Journal:
Future Oncology
DOI:
10.2217/fon-2019-0096
Date:
August, 2019
File:
PDF, 1.29 MB
english, 2019